Elizabeth Whelan writing in National Review Online points out that if Congress approves legislation to legalize the importation of pharmaceuticals from countries which impose ceilings on their price, that this will be a backdoor way to impose implicit price ceilings within the U.S. as our pharmaceutical makers are forced to match prices.
Via Hot Blava.
Comments